Preventive effects of early immunosuppressive treatment on the development of interstitial lung disease in systemic sclerosis.
Velauthapillai A, Bootsma MFR, Bruni C, Bergmann C, Matucci-Cerinic M, Launay D, Riemekastan G, Garzanova L, Airò P, Rezus E, da Silva JAP, Del Galdo F, Hunzelmann N, Chung LS, Krasowska D, Distler O, van den Ende CHM, Vonk MC; EUSTAR collaborators.
Velauthapillai A, et al. Among authors: van den ende chm.
Rheumatology (Oxford). 2024 Jul 22:keae375. doi: 10.1093/rheumatology/keae375. Online ahead of print.
Rheumatology (Oxford). 2024.
PMID: 39037917